nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—Anorexia—Lomustine—brain cancer	0.00468	0.00475	CcSEcCtD
Gadopentetate dimeglumine—Phlebitis—Carmustine—brain cancer	0.0046	0.00467	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Hydroxyurea—brain cancer	0.0046	0.00467	CcSEcCtD
Gadopentetate dimeglumine—Thrombophlebitis—Carmustine—brain cancer	0.00458	0.00465	CcSEcCtD
Gadopentetate dimeglumine—Ear pain—Temozolomide—brain cancer	0.00449	0.00456	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Carboplatin—brain cancer	0.00443	0.0045	CcSEcCtD
Gadopentetate dimeglumine—Thrombophlebitis—Temozolomide—brain cancer	0.00443	0.00449	CcSEcCtD
Gadopentetate dimeglumine—Eye pain—Carmustine—brain cancer	0.00439	0.00446	CcSEcCtD
Gadopentetate dimeglumine—Deafness—Temozolomide—brain cancer	0.00428	0.00435	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Lomustine—brain cancer	0.00427	0.00433	CcSEcCtD
Gadopentetate dimeglumine—Eye pain—Temozolomide—brain cancer	0.00425	0.00431	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Procarbazine—brain cancer	0.00407	0.00413	CcSEcCtD
Gadopentetate dimeglumine—Thirst—Temozolomide—brain cancer	0.00403	0.00409	CcSEcCtD
Gadopentetate dimeglumine—Diplopia—Carmustine—brain cancer	0.00397	0.00403	CcSEcCtD
Gadopentetate dimeglumine—Chills—Procarbazine—brain cancer	0.00393	0.00399	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Procarbazine—brain cancer	0.00392	0.00398	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Lomustine—brain cancer	0.00388	0.00394	CcSEcCtD
Gadopentetate dimeglumine—Diplopia—Temozolomide—brain cancer	0.00383	0.00389	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Carmustine—brain cancer	0.00383	0.00389	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Hydroxyurea—brain cancer	0.00378	0.00384	CcSEcCtD
Gadopentetate dimeglumine—Tension—Procarbazine—brain cancer	0.00375	0.0038	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Temozolomide—brain cancer	0.0037	0.00376	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Procarbazine—brain cancer	0.00358	0.00363	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00358	0.00363	CcSEcCtD
Gadopentetate dimeglumine—Phlebitis—Etoposide—brain cancer	0.00356	0.00361	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00345	0.0035	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Procarbazine—brain cancer	0.00342	0.00348	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Procarbazine—brain cancer	0.00336	0.00341	CcSEcCtD
Gadopentetate dimeglumine—Cough—Procarbazine—brain cancer	0.00333	0.00338	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Procarbazine—brain cancer	0.00331	0.00336	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Procarbazine—brain cancer	0.0033	0.00335	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Procarbazine—brain cancer	0.00325	0.0033	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Procarbazine—brain cancer	0.00324	0.00329	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Procarbazine—brain cancer	0.00318	0.00323	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactoid reaction—Etoposide—brain cancer	0.00317	0.00322	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Procarbazine—brain cancer	0.00314	0.00319	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Lomustine—brain cancer	0.00312	0.00317	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Hydroxyurea—brain cancer	0.00308	0.00313	CcSEcCtD
Gadopentetate dimeglumine—Shock—Procarbazine—brain cancer	0.00307	0.00311	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Temozolomide—brain cancer	0.00306	0.00311	CcSEcCtD
Gadopentetate dimeglumine—Chills—Hydroxyurea—brain cancer	0.00305	0.00309	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Procarbazine—brain cancer	0.00304	0.00309	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Procarbazine—brain cancer	0.00301	0.00306	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Carmustine—brain cancer	0.003	0.00305	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Procarbazine—brain cancer	0.00297	0.00301	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Hydroxyurea—brain cancer	0.00295	0.003	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Etoposide—brain cancer	0.00292	0.00296	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Lomustine—brain cancer	0.00291	0.00296	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Procarbazine—brain cancer	0.00291	0.00296	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00284	0.00288	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Procarbazine—brain cancer	0.0028	0.00284	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Temozolomide—brain cancer	0.00279	0.00284	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Procarbazine—brain cancer	0.00277	0.00281	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00276	0.0028	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Procarbazine—brain cancer	0.00271	0.00275	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Carmustine—brain cancer	0.0027	0.00274	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Carmustine—brain cancer	0.0027	0.00274	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Procarbazine—brain cancer	0.00269	0.00273	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Hydroxyurea—brain cancer	0.00266	0.0027	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Procarbazine—brain cancer	0.00266	0.0027	CcSEcCtD
Gadopentetate dimeglumine—Pain—Procarbazine—brain cancer	0.00266	0.0027	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Carmustine—brain cancer	0.00264	0.00268	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Temozolomide—brain cancer	0.00262	0.00266	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Temozolomide—brain cancer	0.00261	0.00265	CcSEcCtD
Gadopentetate dimeglumine—Bronchospasm—Etoposide—brain cancer	0.00261	0.00265	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Temozolomide—brain cancer	0.00261	0.00264	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Temozolomide—brain cancer	0.0026	0.00264	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Procarbazine—brain cancer	0.00257	0.00261	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Carmustine—brain cancer	0.00256	0.0026	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Hydroxyurea—brain cancer	0.00256	0.0026	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Temozolomide—brain cancer	0.00256	0.00259	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Procarbazine—brain cancer	0.00255	0.00259	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Carmustine—brain cancer	0.00255	0.00258	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Temozolomide—brain cancer	0.00251	0.00254	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.0025	0.00254	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Temozolomide—brain cancer	0.00248	0.00252	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Procarbazine—brain cancer	0.00248	0.00251	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Temozolomide—brain cancer	0.00247	0.00251	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Procarbazine—brain cancer	0.00246	0.0025	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Procarbazine—brain cancer	0.00246	0.0025	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Temozolomide—brain cancer	0.00246	0.0025	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Temozolomide—brain cancer	0.00246	0.0025	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Carmustine—brain cancer	0.00245	0.00249	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Temozolomide—brain cancer	0.00241	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Carmustine—brain cancer	0.0024	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Temozolomide—brain cancer	0.00239	0.00243	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Temozolomide—brain cancer	0.00239	0.00243	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Carmustine—brain cancer	0.00239	0.00242	CcSEcCtD
Gadopentetate dimeglumine—Chills—Temozolomide—brain cancer	0.00238	0.00242	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Hydroxyurea—brain cancer	0.00236	0.0024	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Hydroxyurea—brain cancer	0.00234	0.00238	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Etoposide—brain cancer	0.00233	0.00237	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Etoposide—brain cancer	0.00232	0.00236	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Temozolomide—brain cancer	0.00232	0.00236	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Etoposide—brain cancer	0.00232	0.00235	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Carmustine—brain cancer	0.00231	0.00235	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Temozolomide—brain cancer	0.00231	0.00234	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Hydroxyurea—brain cancer	0.0023	0.00233	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Procarbazine—brain cancer	0.0023	0.00233	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Temozolomide—brain cancer	0.00226	0.00229	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Carmustine—brain cancer	0.00224	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Procarbazine—brain cancer	0.00224	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Etoposide—brain cancer	0.00224	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Temozolomide—brain cancer	0.00223	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Procarbazine—brain cancer	0.0022	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Carmustine—brain cancer	0.00219	0.00223	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Temozolomide—brain cancer	0.00216	0.0022	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Hydroxyurea—brain cancer	0.00215	0.00218	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Hydroxyurea—brain cancer	0.00214	0.00218	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Procarbazine—brain cancer	0.00213	0.00216	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Temozolomide—brain cancer	0.00212	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Temozolomide—brain cancer	0.00211	0.00214	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Hydroxyurea—brain cancer	0.0021	0.00213	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Etoposide—brain cancer	0.0021	0.00213	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00208	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Temozolomide—brain cancer	0.00208	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Etoposide—brain cancer	0.00208	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Hydroxyurea—brain cancer	0.00208	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Carmustine—brain cancer	0.00207	0.0021	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Carmustine—brain cancer	0.00206	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Pain—Hydroxyurea—brain cancer	0.00206	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Hydroxyurea—brain cancer	0.00206	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Procarbazine—brain cancer	0.00206	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Carmustine—brain cancer	0.00203	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Carmustine—brain cancer	0.00203	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Cough—Temozolomide—brain cancer	0.00201	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Etoposide—brain cancer	0.00201	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Temozolomide—brain cancer	0.002	0.00203	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Temozolomide—brain cancer	0.00199	0.00202	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Hydroxyurea—brain cancer	0.00199	0.00202	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Etoposide—brain cancer	0.00198	0.00201	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Procarbazine—brain cancer	0.00198	0.00201	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Etoposide—brain cancer	0.00197	0.002	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Etoposide—brain cancer	0.00197	0.002	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Carmustine—brain cancer	0.00197	0.002	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Temozolomide—brain cancer	0.00197	0.00199	CcSEcCtD
Gadopentetate dimeglumine—Rash—Procarbazine—brain cancer	0.00196	0.00199	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Procarbazine—brain cancer	0.00196	0.00199	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Temozolomide—brain cancer	0.00196	0.00199	CcSEcCtD
Gadopentetate dimeglumine—Headache—Procarbazine—brain cancer	0.00195	0.00198	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00195	0.00198	CcSEcCtD
Gadopentetate dimeglumine—PGD—telencephalon—brain cancer	0.00194	0.13	CbGeAlD
Gadopentetate dimeglumine—Angiopathy—Etoposide—brain cancer	0.00192	0.00195	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Temozolomide—brain cancer	0.00192	0.00195	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Etoposide—brain cancer	0.00192	0.00195	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Etoposide—brain cancer	0.00191	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Hydroxyurea—brain cancer	0.00191	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Chills—Etoposide—brain cancer	0.0019	0.00193	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Carmustine—brain cancer	0.0019	0.00193	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Temozolomide—brain cancer	0.0019	0.00193	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Temozolomide—brain cancer	0.00188	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Carmustine—brain cancer	0.00186	0.00189	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Procarbazine—brain cancer	0.00185	0.00188	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Temozolomide—brain cancer	0.00185	0.00188	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Temozolomide—brain cancer	0.00183	0.00186	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Carmustine—brain cancer	0.00182	0.00185	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Temozolomide—brain cancer	0.00182	0.00185	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Etoposide—brain cancer	0.00181	0.00184	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Temozolomide—brain cancer	0.0018	0.00182	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Etoposide—brain cancer	0.00179	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Hydroxyurea—brain cancer	0.00178	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00178	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Carmustine—brain cancer	0.00175	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Carmustine—brain cancer	0.00174	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Carmustine—brain cancer	0.00173	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Hydroxyurea—brain cancer	0.00173	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00172	0.00174	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Carmustine—brain cancer	0.00169	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Temozolomide—brain cancer	0.00169	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Carmustine—brain cancer	0.00168	0.00171	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Temozolomide—brain cancer	0.00168	0.0017	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Temozolomide—brain cancer	0.00167	0.0017	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Carmustine—brain cancer	0.00167	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Pain—Carmustine—brain cancer	0.00167	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Etoposide—brain cancer	0.00167	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Hydroxyurea—brain cancer	0.00165	0.00167	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Temozolomide—brain cancer	0.00164	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Temozolomide—brain cancer	0.00163	0.00165	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Temozolomide—brain cancer	0.00162	0.00165	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Etoposide—brain cancer	0.00162	0.00165	CcSEcCtD
Gadopentetate dimeglumine—PGD—gonad—brain cancer	0.00162	0.109	CbGeAlD
Gadopentetate dimeglumine—Cough—Etoposide—brain cancer	0.00161	0.00164	CcSEcCtD
Gadopentetate dimeglumine—Pain—Temozolomide—brain cancer	0.00161	0.00164	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Temozolomide—brain cancer	0.00161	0.00164	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Carmustine—brain cancer	0.00161	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Etoposide—brain cancer	0.0016	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Etoposide—brain cancer	0.00159	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Hydroxyurea—brain cancer	0.00159	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Carmustine—brain cancer	0.00159	0.00162	CcSEcCtD
Gadopentetate dimeglumine—PGD—pituitary gland—brain cancer	0.00158	0.106	CbGeAlD
Gadopentetate dimeglumine—Chest pain—Etoposide—brain cancer	0.00157	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00156	0.00159	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Temozolomide—brain cancer	0.00155	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Carmustine—brain cancer	0.00154	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Carmustine—brain cancer	0.00154	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Temozolomide—brain cancer	0.00154	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Hydroxyurea—brain cancer	0.00153	0.00156	CcSEcCtD
Gadopentetate dimeglumine—PGD—medulla oblongata—brain cancer	0.00152	0.102	CbGeAlD
Gadopentetate dimeglumine—Rash—Hydroxyurea—brain cancer	0.00152	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Etoposide—brain cancer	0.00152	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Hydroxyurea—brain cancer	0.00152	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Headache—Hydroxyurea—brain cancer	0.00151	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Etoposide—brain cancer	0.00151	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Temozolomide—brain cancer	0.0015	0.00152	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Temozolomide—brain cancer	0.00149	0.00151	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Temozolomide—brain cancer	0.00149	0.00151	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Etoposide—brain cancer	0.00147	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Etoposide—brain cancer	0.00146	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Etoposide—brain cancer	0.00146	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Etoposide—brain cancer	0.00144	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Carmustine—brain cancer	0.00144	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Hydroxyurea—brain cancer	0.00143	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Etoposide—brain cancer	0.00141	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Carmustine—brain cancer	0.0014	0.00142	CcSEcCtD
Gadopentetate dimeglumine—PGD—midbrain—brain cancer	0.00139	0.0935	CbGeAlD
Gadopentetate dimeglumine—Hypersensitivity—Temozolomide—brain cancer	0.00139	0.00141	CcSEcCtD
Gadopentetate dimeglumine—PGD—spinal cord—brain cancer	0.00136	0.0912	CbGeAlD
Gadopentetate dimeglumine—Paraesthesia—Etoposide—brain cancer	0.00135	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Temozolomide—brain cancer	0.00135	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Etoposide—brain cancer	0.00134	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Etoposide—brain cancer	0.00134	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Carmustine—brain cancer	0.00133	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Temozolomide—brain cancer	0.00133	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Etoposide—brain cancer	0.00131	0.00133	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Etoposide—brain cancer	0.0013	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Etoposide—brain cancer	0.0013	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Carmustine—brain cancer	0.00129	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Pain—Etoposide—brain cancer	0.00129	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Etoposide—brain cancer	0.00129	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Temozolomide—brain cancer	0.00129	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Temozolomide—brain cancer	0.00125	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Etoposide—brain cancer	0.00124	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Carmustine—brain cancer	0.00124	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Etoposide—brain cancer	0.00123	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Rash—Carmustine—brain cancer	0.00123	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Carmustine—brain cancer	0.00123	0.00125	CcSEcCtD
Gadopentetate dimeglumine—PGD—endocrine gland—brain cancer	0.00122	0.0821	CbGeAlD
Gadopentetate dimeglumine—Headache—Carmustine—brain cancer	0.00122	0.00124	CcSEcCtD
Gadopentetate dimeglumine—PGD—head—brain cancer	0.00121	0.0811	CbGeAlD
Gadopentetate dimeglumine—Vomiting—Temozolomide—brain cancer	0.0012	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Etoposide—brain cancer	0.0012	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Etoposide—brain cancer	0.00119	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Etoposide—brain cancer	0.00119	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Rash—Temozolomide—brain cancer	0.00119	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Temozolomide—brain cancer	0.00119	0.0012	CcSEcCtD
Gadopentetate dimeglumine—Headache—Temozolomide—brain cancer	0.00118	0.0012	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Carmustine—brain cancer	0.00116	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Temozolomide—brain cancer	0.00112	0.00114	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Etoposide—brain cancer	0.00111	0.00113	CcSEcCtD
Gadopentetate dimeglumine—PGD—central nervous system—brain cancer	0.0011	0.074	CbGeAlD
Gadopentetate dimeglumine—Asthenia—Etoposide—brain cancer	0.00108	0.0011	CcSEcCtD
Gadopentetate dimeglumine—PGD—cerebellum—brain cancer	0.00108	0.0723	CbGeAlD
Gadopentetate dimeglumine—Pruritus—Etoposide—brain cancer	0.00107	0.00108	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Etoposide—brain cancer	0.00103	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Etoposide—brain cancer	0.000997	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Etoposide—brain cancer	0.000958	0.000973	CcSEcCtD
Gadopentetate dimeglumine—Rash—Etoposide—brain cancer	0.00095	0.000965	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Etoposide—brain cancer	0.00095	0.000964	CcSEcCtD
Gadopentetate dimeglumine—Headache—Etoposide—brain cancer	0.000944	0.000959	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Etoposide—brain cancer	0.000895	0.000909	CcSEcCtD
Gadopentetate dimeglumine—PGD—brain—brain cancer	0.000876	0.0587	CbGeAlD
